It gives us great pleasure to share with you that we have been recognized as a finalist in the 2021 Citeline Awards for Best Patient-Facing Technology initiative. Clinion eCOA has been named a finalist for the Citeline Awards (previously known as the CARE Awards).
This award recognizes the promising and disruptive role that Patient engagement technology plays in clinical trials. Clinion eCOA has been named as a finalist for providing a superior experience to patients participating in clinical trials as well as unlocking increased efficiencies in the overall clinical trials process for sponsors, sites, and CROs.
“With COVID-19 largely disrupting clinical trials, life sciences industries, empowered with technology, are transitioning to decentralized or virtual trials that mitigate the inefficiencies linked with the traditional site-centric approach and integrate clinical trials into the day-to-day lives of patients,” said Manuj Vangipurapu, CEO & Founder, Clinion. “This award emphasizes our focus on empowering life sciences organizations with breakthrough technologies and broad cross-stakeholder partnerships to facilitate decentralized trials, thereby greatly improving patient engagement, and enhancing protocol adherence and outcomes.”
To know more about the Clinion eCOA, please visit https://www.clinion.com/ecoa-solutions-for-clinical-trials/
or
Write to us at info@clinion.com
About Citeline Awards:
The Citeline Awards recognize accomplishments across the biopharmaceutical industry, providing an opportunity for the industry to honor its highest achievers. Achievements across the spectrum of key R&D activities are celebrated, from successes in early and late-stage research, to advances in technological tools, to innovations in trial design and execution.
